Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Madrigal Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 135 | 3 | 189 | +57 |
| Shares | 11.7M | 7.31K | 13.3M | +1.60M (+13.6%) |
| Value | $763.2M | $474.5K | $3.86B | +$3.10B (+406.2%) |
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (80)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (23)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Federated Hermes, Inc. | 240,000 | $15.6M |
| Great Point Partners LLC | 95,500 | $6.21M |
| Point72 Asset Management, L.P. | 22,876 | $1.49M |
| UBS Asset Management Americas Inc | 16,634 | $1.08M |
| Group One Trading, L.P. | 16,534 | $1.07M |
| EP Wealth Advisors, LLC | 13,862 | $901.0K |
| Millennium Management LLC | 11,738 | $763.0K |
| Picton Mahoney Asset Management | 11,215 | $728.0K |
| HighVista Strategies LLC | 9,527 | $619.0K |
| ExodusPoint Capital Management, LP | 9,177 | $596.0K |
| Man Group plc | 7,600 | $494.0K |
| PDT Partners, LLC | 6,524 | $424.0K |
| Occudo Quantitative Strategies LP | 5,789 | $376.0K |
| International Biotechnology Trust PLC | 5,350 | $348.0K |
| Simplex Trading, LLC | 4,850 | $315.0K |
| Ensign Peak Advisors, Inc | 4,580 | $298.0K |
| Walleye Trading LLC | 3,936 | $256.0K |
| Dynamic Technology Lab Private Ltd | 3,150 | $205.0K |
| Aquatic Capital Management LLC | 2,300 | $149.0K |
| Amundi | 1,249 | $91.0K |
| CSS LLC | 544 | $35.0K |
| Cutler Group LP | 50 | $3.00K |
| Dark Forest Capital Management LP | 8 | $1.00K |
Not filed for Q4 2022 yet (3)
Institutions that held Madrigal Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Shikiar Asset Management Inc | 6,500 | $422.0K |
| Covington Capital Management | 743 | $48.0K |
| American Portfolios Advisors | 70 | $4.55K |